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Background: India has a huge burden of infectious diseases and
management of some of thesewarrants use of antibiotics. However
there is rampant overuse and misuse of antibiotics in situations
where they are not needed. As a result India is experiencing rising
trends of antimicrobial resistance both in hospitals and communi-
ties. An effectiive infection control and antimicrobial stewardship
program(AMSP)arepivotal in reducing theantimicrobial resistance
burden in any hospital setting.
Methods & Materials: Indian Council of Medical Research
carried out a survey in the Government and private corporate hos-
pitals to understand the quality of infection control and antibiotic
stewardship activities being practiced.The survey looked at the
availabilty of the following:
1. infection control guideline,
2. antimicrobial stewardship guideline and strategy employed
for AMSP,
3. Standard guidelines for treatment
4. Collection and analysis of anti Microbial resistance data of
pathogens
4. Collection of antimicrobial usage data
5. Mechanism of monitoring and auditing followed in the hos-
pital
Results: The results from the survey indicate that while most of
the hospitals have guidance document on infection control but the
infrastructure required is often lacking in hospitals. Similarly the
hospitals do not have standard treatment guidelines and even if
they are present they are not strictly followed. The monitoring and
audit of antimicrobial usage is rarity.
Conclusion: This survey highlights the need to strengthen the
have a uniform infection control practices in the country and also
have standard treatment guidelines for all hospitals which can be
customised based on the hospital requirement. There is also need
for better coordination among the microbiologists and physicians.
There is a need to put in place the monitoring and auditing mech-
anisms in almost all the hospitals.
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Background: Serious gram-positive bacterial infections are
common in childhood. Linezolid is the ﬁrst member of oxazolidi-
none group in the clinical use. It shows its effect by inhibiting
the 50S ribosome. However, myelosuppression has been reported
as a side-effect. In this study, we aimed to show the effective-
ness of pyridoxine against linezolid induced side-effects (oxidative
stress and hematological complications) on an experimental ani-
mal model.
Methods & Materials: Forty male pediatric Spraque Dawley
rats were randomly seperated into four groups. We administered
1mL of saline solution to the control group (C), 125mg/kg/day of
linezolid to second group (L), 100mg/kg/day of pyridoxine to the
third group (P) and 125mg/kg/day of linezolid plus 100mg/kg/day
pyridoxine to the last group (LP)for 14 days per 12hours. Before
and after this procedure, we measured complete blood count, BUN,
creatinine, ALT, AST, total and direct bilirubin values. Glutathione
peroxidase (GSH-Px), superoxide dismutase (SOD), catalase (CAT)
and malondialdehyde (MDA) levels were measured in the erythro-
cytes to show oxidative stress. All analyses were made with SPSS
program and p<0.05 was considered statistically signiﬁcant.
Results: There was a signiﬁcant decrease in white cell number
in L, P and LP groups when compared to control group (p<0.0001).
Serum ALT levels of L group was signiﬁcantly higher than control
group (p<0.0001). Activity of antioxidant enzymes SOD, GSH-Px
and CAT, and level of serum MDA were higher than control group
in L group. Level of MDA, which is an indicator of lipid peroxida-
tion, and antioxidant enzymeactivitiesweredecreased in L+P given
group.
Conclusion: Total leukocyte count was decreased but levels of
MDA, ALT and activities of SOD, GSH-Px and CAT were increased
signiﬁcantly in the linezolid group when compared to the control
and LP groups. These ﬁndings suggest that pyridoxine has no pro-
tective effects for linezolid-induced leukopenia and increased ALT
levels.On theotherhand, pyridoxinemayprotect against theoxida-
tive stress that occurs in erythrocytes by reducing the activity of
antioxidant enzymes and MDA levels. This study, ﬁrst in the litera-
ture, examined the side effects of linezolid in pediatric rats andwill
hopefully be a source for the future researches.
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